Pathogenesis and management of abdominal aortic aneurysm

Pathogenesis and management of abdominal aortic aneurysm

Graphical Abstract Graphical Abstract Potential medical therapies to limit abdominal aortic aneurysm growth or rupture. VSMC, vascular smooth muscle cell; LDL, low density lipoprotein. Abstract Abdominal aortic aneurysm (AAA) causes ∼170 000 deaths annually worldwide. Most guidelines recommend asymp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European heart journal 2023-08, Vol.44 (29), p.2682-2697
Hauptverfasser: Golledge, Jonathan, Thanigaimani, Shivshankar, Powell, Janet T, Tsao, Phil S
Format: Artikel
Sprache:eng
Schlagworte:
Aneurysm, Ruptured
Anti-Bacterial Agents - therapeutic use
Aortic Aneurysm, Abdominal - diagnosis
Aortic Aneurysm, Abdominal - therapy
Aortic Rupture
Female
Genome-Wide Association Study
Humans
Male
Prospective Studies
State of the Art Review
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Graphical Abstract Graphical Abstract Potential medical therapies to limit abdominal aortic aneurysm growth or rupture. VSMC, vascular smooth muscle cell; LDL, low density lipoprotein. Abstract Abdominal aortic aneurysm (AAA) causes ∼170 000 deaths annually worldwide. Most guidelines recommend asymptomatic small AAAs (30 to
ISSN:0195-668X
1522-9645
DOI:10.1093/eurheartj/ehad386